Covid-19 drives record boom in biotech IPOs – Wall Street Journal

So far this year, US-listed biotech companies have raised roughly $9.4 billion in IPOs this year, already beating the $6.5 billion raised in all of 2018.

So far this year, US-listed biotech companies have raised roughly $9.4 billion in IPOs this year, already beating the $6.5 billion raised in all of 2018.

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).